[The content of cholylglycine in the blood serum in cholelithiasis during treatment with litholytic preparations of bile acids].
Liver function has been assessed on the basis of radioimmunoassays of the primary conjugated cholic acid, cholylglycine, in the blood sera of cholelithiasis patients treated with cheno- and ursodeoxycholic acid drugs for a long time. The findings indicate that the blood serum cholylglycine levels may be regarded, among other things, as a prognostic criterion of the efficacy of cholelithiasis therapy with bile acid preparations for litholysis.
Bocharova
L V
LV
Genia
L P
LP
Lemeshko
Z A
ZA
Petrova
E A
EA
D000328:Adult; D000368:Aged; D002635:Chenodeoxycholic Acid / Q000627:therapeutic use*; D002769:Cholelithiasis / Q000097:blood / Q000188:drug therapy*; D003840:Deoxycholic Acid / Q000031:analogs & derivatives*; D005260:Female; D006000:Glycocholic Acid / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
D003840:Deoxycholic Acid; D002635:Chenodeoxycholic Acid; D014580:Ursodeoxycholic Acid; D006000:Glycocholic Acid
Soderzhanie kholilglitsina v syvorotke krovi pri zhelchnokamennoĭ bolezni v protsesse lecheniia kamnerastvoriaiushchimi preparatami zhelchnykh kislot.